ACADIA Pharmaceuticals, Inc.
3911 Sorrento Valley Boulevard
San Diego
California
92121
U.S.A.
Phone:
858-558-2871
Fax:
858-558-2872
|
ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA currently has five mid-to-late stage clinical programs as well as a portfolio of preclinical and discovery assets directed at diseases with large unmet medical needs, including schizophrenia, Parkinson’s disease psychosis, sleep maintenance insomnia, and neuropathic pain. All of the drug candidates in ACADIA’s product pipeline emanate from discoveries made using its proprietary drug discovery platform. ACADIA’s corporate headquarters is located in San Diego, California and it maintains research and development operations in both San Diego and Malmö, Sweden.
SENIOR MANAGEMENT
Uli Hacksell, Ph.D.
Chief Executive Officer and Director
Thomas H. Aasen
Vice President, Chief Financial Officer, Secretary and Treasurer
Roger G. Mills, M.D.
Executive Vice President, Development
Brian Lundstrom
Senior Vice President, Business Development
Bo-Ragnar Tolf, Ph.D.
Vice President, Chemistry, and Managing Director of ACADIA Pharmaceuticals AB
Last Updated: 07-24-2007
Email:
lbarthelemy@acadia-pharm.com
Ownership:
Web Site:
ACADIA Pharmaceuticals, Inc.
Employees:
140
Symbol: ACAD
|
| Collaborations |
|
Allergan Inc.
Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.
|
|
Allergan Inc.
Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.
|
|
Allergan Inc.
The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.
|
|
Sepracor, Inc.
ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.
|
|
|
Company News |
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Third Quarter 2009 Financial Results
11/10/2009 9:55:05 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) to Announce Third Quarter 2009 Financial Results on November 9, 2009
11/2/2009 9:40:43 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) to Present at the BIOCOM Investor Conference on October 26, 2009
10/20/2009 8:47:39 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) to Present at the JMP Securities Healthcare Focus Conference on October 6, 2009
10/6/2009 8:37:31 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD), Biovail Corporation (BVF) Plan More Study on Parkinson's Drug
10/6/2009 6:25:40 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD), Biovail Corporation (BVF)'s Psychosis Drug Misses Primary Goal
9/1/2009 6:49:53 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Reports Second Quarter 2009 Financial Results
8/6/2009 9:38:05 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) Shares Soar Ahead Of Late-Stage Trial Results
7/27/2009 8:37:04 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) to Present at the Eighth Annual Needham Life Sciences Conference on June 10, 2009
6/3/2009 8:31:03 AM
More...
|
ACADIA Pharmaceuticals, Inc. (ACAD) to Present at the Eighth Annual JMP Securities Research Conference on May 19, 2009
5/13/2009 8:47:43 AM
More...
|
|
|
|